Isolation and preliminary characterization of a human ‘phage display’-derived antibody against neural adhesion molecule-1 antigen interfering with fibroblast growth factor receptor-1 binding
Human Antibodies · 24.03.2021 · 29 (1) · 63-84
DOI: 10.3233/hab-200431 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Antibodies, erschienen am 24.03.2021. Verfasst von Michela Flego und 12 weiteren Autor:innen. Beteiligte Einrichtung: National Center for Global Health, Istituto Superiore di Sanità, Rome, Italy. Hauptthemen laut MEDLINE: Bacteriophages, Signal Transduction. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 53 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: The NCAM or CD56 antigen is a cell surface glycoprotein belonging to the immunoglobulin super-family involved in cell-cell and cell-matrix adhesion. NCAM is also over-expressed in many tumour types and is considered a tumour associated antigen, even if its role and biological mechanisms implicated in tumour progression and metastasis have not yet to be elucidated. In particular, it is quite well documented the role of the interaction between the NCAM protein and the fibroblast growth factor receptor-1 in metastasis and invasion, especially in the ovarian cancer progression. OBJECTIVE: Here we describe the isolation and preliminary characterization of a novel human anti-NCAM single chain Fragment variable antibody able to specifically bind NCAM-expressing cells, including epithelial ovarian cancer cells. METHODS: The antibody was isolate by phage display selection and was characterized by ELISA, FACS analysis and SPR experiments. Interference in EOC migration was analyzed by scratch test. RESULTS: It binds a partially linear epitope lying in the membrane proximal region of two fibronectin-like domains with a dissociation constant of 3.43 × 10-8 M. Interestingly, it was shown to interfere with the NCAM-FGFR1 binding and to partially decrease migration of EOC cells. CONCLUSIONS: According to our knowledge, this is the first completely human antibody able to interfere with this newly individuated cancer mechanism.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Center for Global Health, Istituto Superiore di Sanità, Rome, Italy.
- Institute of Molecular Biology and Pathology, Italian National Research Council, c/o Department Biochemical Sciences, Sapienza University of Rome, Rome, Italy.
- National Center for Control and Evaluation of Medicine, Istituto Superiore di Sanità, Rome, Italy.
- Center for Gender Specific Medicine, Istituto Superiore di Sanità, Rome, Italy.
- Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy.
- Core Facilities, Istituto Superiore di Sanità, Rome, Italy.
Zitieren
APA
Flego, M., Colotti, G., Ascione, A., Dupuis, M. L., Petrucci, E., Riccioni, R., Andreotti, M., Raggi, C., Boe, A., Barca, S., Gellini, M., Vella, S., & Mallano, A. (2021). Isolation and preliminary characterization of a human ‘phage display’-derived antibody against neural adhesion molecule-1 antigen interfering with fibroblast growth factor receptor-1 binding. Human Antibodies, 29(1), 63-84. https://doi.org/10.3233/hab-200431
Vancouver
Flego M, Colotti G, Ascione A, Dupuis ML, Petrucci E, Riccioni R, et al. Isolation and preliminary characterization of a human ‘phage display’-derived antibody against neural adhesion molecule-1 antigen interfering with fibroblast growth factor receptor-1 binding. Human Antibodies. 2021;29(1):63-84. doi:10.3233/hab-200431
BibTeX
@article{Flego2021,
author = {Flego, Michela and Colotti, Gianni and Ascione, Alessandro and Dupuis, Maria Luisa and Petrucci, Eleonora and Riccioni, Roberta and Andreotti, Mauro and Raggi, Carla and Boe, Alessandra and Barca, Stefano and Gellini, Mara and Vella, Stefano and Mallano, Alessandra},
title = {Isolation and preliminary characterization of a human ‘phage display’-derived antibody against neural adhesion molecule-1 antigen interfering with fibroblast growth factor receptor-1 binding},
journal = {Human Antibodies},
year = {2021},
volume = {29},
number = {1},
pages = {63--84},
doi = {10.3233/hab-200431}
}
EUVIMED